SG10201610317VA - Antibodies against cd38 for treatment of multiple myeloma - Google Patents
Antibodies against cd38 for treatment of multiple myelomaInfo
- Publication number
- SG10201610317VA SG10201610317VA SG10201610317VA SG10201610317VA SG10201610317VA SG 10201610317V A SG10201610317V A SG 10201610317VA SG 10201610317V A SG10201610317V A SG 10201610317VA SG 10201610317V A SG10201610317V A SG 10201610317VA SG 10201610317V A SG10201610317V A SG 10201610317VA
- Authority
- SG
- Singapore
- Prior art keywords
- treatment
- antibodies against
- multiple myeloma
- myeloma
- antibodies
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2896—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200500429 | 2005-03-23 | ||
| US66757905P | 2005-04-01 | 2005-04-01 | |
| US69616305P | 2005-07-01 | 2005-07-01 | |
| US72856105P | 2005-10-20 | 2005-10-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201610317VA true SG10201610317VA (en) | 2017-02-27 |
Family
ID=50644285
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201610317VA SG10201610317VA (en) | 2005-03-23 | 2006-03-23 | Antibodies against cd38 for treatment of multiple myeloma |
Country Status (12)
| Country | Link |
|---|---|
| KR (1) | KR20140033240A (enExample) |
| BE (1) | BE2017C062I2 (enExample) |
| DK (1) | DK1866338T3 (enExample) |
| ES (2) | ES2644982T3 (enExample) |
| HU (2) | HUE030783T2 (enExample) |
| LT (2) | LT2567976T (enExample) |
| NZ (2) | NZ600059A (enExample) |
| PL (1) | PL1866338T3 (enExample) |
| PT (2) | PT2567976T (enExample) |
| RS (1) | RS55442B1 (enExample) |
| SG (1) | SG10201610317VA (enExample) |
| UA (2) | UA98756C2 (enExample) |
-
2006
- 2006-03-23 KR KR1020147004315A patent/KR20140033240A/ko not_active Ceased
- 2006-03-23 LT LTEP12178778.2T patent/LT2567976T/lt unknown
- 2006-03-23 HU HUE06722861A patent/HUE030783T2/en unknown
- 2006-03-23 SG SG10201610317VA patent/SG10201610317VA/en unknown
- 2006-03-23 ES ES12178778.2T patent/ES2644982T3/es not_active Expired - Lifetime
- 2006-03-23 UA UAA200711639A patent/UA98756C2/ru unknown
- 2006-03-23 ES ES06722861.9T patent/ES2606762T3/es not_active Expired - Lifetime
- 2006-03-23 RS RS20161147A patent/RS55442B1/sr unknown
- 2006-03-23 NZ NZ600059A patent/NZ600059A/en not_active Application Discontinuation
- 2006-03-23 PT PT121787782T patent/PT2567976T/pt unknown
- 2006-03-23 PT PT67228619T patent/PT1866338T/pt unknown
- 2006-03-23 UA UAA201204050A patent/UA116520C2/uk unknown
- 2006-03-23 PL PL06722861T patent/PL1866338T3/pl unknown
- 2006-03-23 LT LTEP06722861.9T patent/LT1866338T/lt unknown
- 2006-03-23 HU HUE12178778A patent/HUE034962T2/en unknown
- 2006-03-23 DK DK06722861.9T patent/DK1866338T3/da active
- 2006-03-23 NZ NZ625944A patent/NZ625944A/en unknown
-
2017
- 2017-11-30 BE BE2017C062C patent/BE2017C062I2/nl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2606762T3 (es) | 2017-03-27 |
| LT2567976T (lt) | 2017-12-11 |
| KR20140033240A (ko) | 2014-03-17 |
| NZ625944A (en) | 2016-01-29 |
| UA98756C2 (ru) | 2012-06-25 |
| RS55442B1 (sr) | 2017-04-28 |
| DK1866338T3 (da) | 2017-01-02 |
| HUE030783T2 (en) | 2017-06-28 |
| HUE034962T2 (en) | 2018-03-28 |
| BE2017C062I2 (enExample) | 2025-12-03 |
| LT1866338T (lt) | 2017-01-25 |
| PL1866338T3 (pl) | 2017-04-28 |
| UA116520C2 (uk) | 2018-04-10 |
| PT1866338T (pt) | 2016-12-14 |
| PT2567976T (pt) | 2017-10-19 |
| ES2644982T3 (es) | 2017-12-01 |
| NZ600059A (en) | 2016-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL304150A (en) | Antibodies against 38cd for the treatment of multiple myeloma | |
| HRP20181565T1 (hr) | Monoklonska protutijela protiv klaudina-18 za liječenje karcinoma | |
| SI2029155T1 (sl) | Izboljšano zdravljenje multiplega mieloma | |
| IL243687A0 (en) | For the treatment of multiple myeloma 1–cs antibodies against | |
| PT1962913E (pt) | Radioimunoconjugado para cd66 humano para o tratamento de mieloma múltiplo | |
| HUS1700054I1 (hu) | CD38-ellenes antitestek a mielóma multiplex kezelésére | |
| SG10201610317VA (en) | Antibodies against cd38 for treatment of multiple myeloma |